Because high-risk MM is characterized by aggressive proliferation, we measured CHEK1 mRNA expression in MM subgroups, and found that CHEK1 expression was highest in the PR subgroup, considered the highest-risk MM subgroup (Fig. 2C) [22]. The gene discussed is CHEK1; the disease is Miyoshi myopathy.